News

NIH R01 grant awarded!

The McFarland group has been awarded an R01 grant from the National Institutes of Health / National Cancer Institute. This funding will allow us to apply our successful development of photo-activated cancer drugs to treat melanoma.

More information is available here: https://projectreporter.nih.gov/project_info_description.cfm?aid=9543160